NCT05572684
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05572684
Title A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NextCure, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Oncology Associates Tucson Arizona 85711 United States Details
Rocky Mountain Cancer Centers Aurora Colorado 80012 United States Details
St. Elizabeth Edgewood Hospital Edgewood Kentucky 41017 United States Details
Ochsner Cancer Institute New Orleans Louisiana 70121 United States Details
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21231 United States Details
Hackensack Meridian Health University Medical Center- John Theurer Cancer Center Hackensack New Jersey 07601 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14203 United States Details
NYU Langone Health New York New York 10016 United States Details
University of Cincinnati Cancer Center Cincinnati Ohio 45267 United States Details
UT Southwestern Medical Center Dallas Texas 75235 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
UT Health San Antonio San Antonio Texas 78229 United States Details
Texas Oncology - San Antonio San Antonio Texas 78240 United States Details
Inova Schar Cancer Institute Fairfax Virginia 22031 United States Details
Virginia Cancer Specialist Fairfax Virginia 22031 United States Details
Northwest Cancer Specialist Vancouver Washington 98684 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field